Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on NOVARTIS AG
03/10 NOVARTIS : Carlsbad's Genoptix sold to investor group
03/09 NOVARTIS : Patent Issued for Optical Structures with Nanostructre Features and M..
03/09 NOVARTIS : Patent Issued for Surgical Cassette with Compliant Clamping Zone (USP..
03/09 NOVARTIS : Patent Issued for Tracking System for Surgical Optical Coherence Tomo..
03/08 Compare and contrast - Trump's tweets vs private comments to CEOs
03/08 POSITIVE RESULTS FOR ABBVIE INC (NYS : ABBV) Humira Biosimilar Reported By Novar..
03/07 European shares slip as Trump tweet hits drugmakers
03/06 NOVARTIS : ' Cosentyx shows almost all psoriasis patients rapidly regain skin cl..
03/06 NOVARTIS : New data demonstrate Sandoz proposed biosimilar adalimumab has equiva..
03/03 NOVARTIS AG (ADR) (NYSE : NVS) Fined And Some Products To Be Temporarily Suspend..
03/02 NOVARTIS : Patent Issued for Colored Contact Lenses and Method of Making the Sam..
03/02 NOVARTIS : Patent Issued for Compounds and Compositions as Kinase Inhibitors (US..
03/02 NOVARTIS : Patent Issued for Sub-Micron Alignment of a Monitoring Fiber for Opti..
03/02 NOVARTIS : Patent Issued for Intraocular Pressure Sensing System for Posterior S..
03/02DJNOVARTIS : Fined by South Korea Over Alleged Kickbacks
03/02 NOVARTIS : South Korea fines Novartis over kickbacks, suspends sales of some dru..
03/02 NOVARTIS : South Korea fines Novartis over kickbacks, suspends sales of some dru..
03/02 LUPIN : Launches solution for skin inflammation
03/02 NOVARTIS AG : ex-dividend day for annual dividend
02/28 EXCLUSIVE : Merus Labs hires Rothschild to explore options - sources
02/28 NOVARTIS : shareholders approve all resolutions proposed by Board of Directors a..
02/27 NOVARTIS : receives positive CHMP opinion for Tafinlar + Mekinist in BRAF-positi..
02/24 NOVARTIS : U.S. Patents Awarded to Inventors in Virginia (Feb. 24)
02/24 NOVARTIS AG : Blog Coverage Novartis Gains Priority Review from the FDA for its ..
02/24 NOVARTIS : receives positive CHMP opinion for Tafinlar® + Mekinist® in BRAF-posi..
02/24 NOVARTIS : Patent Issued for Methods of Nuclease-Based Genetic Engineering (USPT..
02/23 NOVARTIS : drug Zykadia receives FDA Priority Review for first-line use in patie..
02/22 MANUFACTURING DELAY OF GENERIC DRUG : PFE) A Relief For Teva Pharmaceutical Ind..
02/16 JOHNSON & JOHNSON : Nancy-Ann DeParle and Dr. Scott Gottlieb Join Executives fro..
02/15 NOVARTIS : Sources Sought Notice - Alcon Wavecards
02/14 IMMUNICUM : Appoints Karin Hoogendoorn as Head of CMC
02/09 NOVARTIS : Patent Issued for Microscope-Less Wide Field-Of-View Surgical OCT Vis..
02/09 NOVARTIS : Patent Issued for Ocular Implant Delivery Systems and Methods (USPTO ..
02/09 NOVARTIS : Ampersand Capital Partners and 1315 Capital to Acquire Genoptix
02/08 NOVARTIS : Medical researchers using new tools to turn science fiction into scie..
02/06 New GlaxoSmithKline CEO prepares for R&D choices, potential deals
02/03 Microsoft, Coca-Cola, Novartis, L`Oral, Nokia and more Join Ethisphere`s Glob..
02/02 NOVARTIS : Patent Issued for Complement Pathway Modulators and Uses (USPTO 95507..
02/02 NOVARTIS : Patent Issued for Ocular Implant Applier and Methods of Use (USPTO 95..
02/02 NOVARTIS : Patent Issued for Drug Delivery Devices and Methods (USPTO 9549846)
02/02 NOVARTIS : Patent Issued for Partial Venting System for Occlusion Surge Mitigati..
02/02 NOVARTIS : Patent Issued for Surgical Hand Piece with Integrated Pressure Sensor..
02/02 Microsoft, Coca-Cola, Novartis, L'Oréal, Nokia and more Join Ethisphere's Glo..
02/02 NOVARTIS : unit Lek to expand Slovenian antibiotics plant
02/02 NOVARTIS : UNECE Prepares Guidance on Fire-Water Retention to Avoid Another Sand..
01/31 Trump meets with drugmakers, seeks lower prices, US production
01/31 Trump meets with drugmakers, seeks lower prices, U.S. production
01/31 NOVARTIS : drug Votubia® receives EU approval to treat refractory partial-onset ..
01/30 NOVARTIS : highlights progress towards access and environmental goals in 2016 Co..
01/30 NOVARTIS : Alcon launches new trifocal toric intraocular lens for patients with ..
01/30 Swiss vote on multinational tax perks in February referendum
01/27 NOVARTIS : Special Notice - Intent to Sole Source-ALCON Ophthalmic Implants and ..
01/26 NOVARTIS : Patent Issued for Systems and Methods for Ocular Surgery (USPTO 95453..
01/26 NOVARTIS : Patent Issued for Acoustic Streaming Glaucoma Drainage Device (USPTO ..
01/26 NOVARTIS AG : Blog Coverage Novartis Announced Buyback of Shares Worth $5 Billio..
01/26DJNOVARTIS : Weighs Alcon Spinoff -- WSJ
01/26 NOVARTIS : highlights progress towards access and environmental goals in 2016 Co..
01/26 NOVARTIS : Alcon launches new trifocal toric intraocular lens for patients with ..
01/25 AMGEN : Novartis says court battle will delay its Enbrel copy until 2018 at leas..
01/25 NOVARTIS : beats 4Q profit forecasts
01/25DJVECTURA : Says Bronchitis Inhaler Sales Trigger Milestone Payment
01/25DJNOVARTIS : May Spin Off Alcon Eye-Care Business -- Update
01/25 NOVARTIS CEO : "The bigger the target, the higher the premium"
01/25 VECTURA : Says Novartis' Sales Of Breezhaler Products Hit USD512 Million
01/25DJNOVARTIS : Announces Share Buyback as Dollar Hits Earnings
01/25 NOVARTIS : delivered solid 2016 performance, with Growth Products absorbing Glee..
01/19 NOVARTIS : Patent Issued for Solid Oral Formulations and Crystalline Forms of an..
01/19 NOVARTIS : Patent Issued for MELK Regulation for the Treatment of Breast Cancer ..
01/19 NOVARTIS : Patent Issued for Integrated OCT-Refractometer System for Ocular Biom..
01/19 Davos CEOs 'go local' on supply chain in Trump era
01/18 Drugmakers in Davos shift focus to chronic diseases of poor
01/16 NOVARTIS : invests in next generation therapies to reduce cardiovascular risk in..
01/13DJNOVARTIS : Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs
01/13 NOVARTIS : NICE approves kidney cancer drug for NHS use
01/12 NOVARTIS : "Combination Therapy Comprising an Inhibitor of Jak, Cdk, and Pim" in..
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ($)
Sales 2017 48 498 M
EBIT 2017 11 367 M
Net income 2017 7 543 M
Debt 2017 15 250 M
Yield 2017 3,80%
P/E ratio 2017 22,39
P/E ratio 2018 19,62
EV / Sales 2017 4,35x
EV / Sales 2018 4,14x
Capitalization 195 490 M
More Financials
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Full-screen chart
Technical analysis trends NOVARTIS AG
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 31
Average target price 79,4 $
Spread / Average Target 6,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Joseph Jimenez Chief Executive Officer
Hans Jörg Reinhardt Independent Non-Executive Chairman
Harry Kirsch Chief Financial Officer
Vasant Narasimhan Chief Medical Officer & Head-Drug Development
Srikant Madhav Datar Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NOVARTIS AG-1.08%195 490
JOHNSON & JOHNSON6.67%333 142
ROCHE HOLDING LTD.8.21%220 797
PFIZER INC.3.88%200 926
MERCK & CO., INC.5.55%170 359
SANOFI10.33%119 103
More Results